NovaBridge Biosciences (NBP) Revenue (2019 - 2023)

NovaBridge Biosciences (NBP) has reported Revenue for 4 consecutive years, with $5000.0 the latest figure, recorded in Q4 2023.

• In Q4 2023, Revenue fell 99.67% year-over-year to $5000.0; the TTM figure through Dec 2023 stood at $2.0 million (down 68.72% YoY), while the FY2023 annual figure was $632000.0, down 59.25% from the prior year.
• Revenue eased to $5000.0 in Q4 2023 per NBP's latest filing, from $315000.0 in the prior quarter.
• Across five years, Revenue topped out at $2.7 million in Q4 2020 and bottomed at $5000.0 in Q4 2023.
• Historically, Revenue has averaged $1.1 million across 4 years, with a median of $907500.0 in 2022.
• On a YoY basis, Revenue climbed as much as 99.67% in 2023 and fell as far as 99.67% in 2023.
• NovaBridge Biosciences' Revenue stood at $2.1 million in 2019, then increased by 25.51% to $2.7 million in 2020, then tumbled by 44.15% to $1.5 million in 2022, then tumbled by 99.67% to $5000.0 in 2023.
• Business Quant data shows NBP's Revenue at $5000.0 in Q4 2023, $315000.0 in Q3 2023, and $159000.0 in Q2 2023.